VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 100 filers reported holding VERONA PHARMA PLC in Q3 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $912,800 | -21.5% | 56,000 | +1.8% | 0.52% | -19.7% |
Q2 2023 | $1,162,700 | +5.3% | 55,000 | 0.0% | 0.64% | -15.4% |
Q1 2023 | $1,104,400 | -23.2% | 55,000 | 0.0% | 0.76% | -46.3% |
Q4 2022 | $1,437,150 | +251.4% | 55,000 | +37.5% | 1.42% | +238.1% |
Q3 2022 | $409,000 | – | 40,000 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |